기관절개용 제품 시장 규모, 점유율, 동향 분석 리포트 : 유형별, 인구통계학별, 시술별, 최종 용도별, 부문별 예측(2025-2030년)

Tracheostomy Products Market Size, Share & Trends Analysis Report By Type (Tracheostomy Tubes, Ventilation Accessories), By Demographics (Adults, Pediatrics/Neonatal), By Technique, By End Use, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,464,000

Unprintable PDF & Excel (Single User License)

보고서 PDF 및 엑셀을 1인만 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 불가능합니다.

US $ 6,950 ￦ 9,887,000

Printable PDF & Excel (5-User License)

보고서 PDF 및 엑셀을 동일 기업 내 동일 부서에서 최대 5명까지 사용할 수 있는 라이선스입니다. 텍스트 등의 복사 및 붙여넣기, 인쇄는 가능합니다.

US $ 8,950 ￦ 12,732,000

Printable PDF & Excel (Enterprise License)

보고서 구매 기업 및 그 자회사, 관계사가 사용할 수 있는 라이선스이며, PDF 및 엑셀 텍스트 등의 복사 및 붙여넣기, 인쇄가 가능합니다.

한글목차

기관절개용 제품 시장 성장과 동향

Grand View Research, Inc.의 최신 리포트에 따르면 세계의 기관절개용 제품 시장 규모는 2030년까지 2억 7,870만 달러에 달하며, 2025-2030년 CAGR은 4.3%로 확대할 것으로 추정되고 있습니다.

심혈관 질환(CVDs), 당뇨병, 호흡기 질환, 암, 기타 호흡기 손상과 같은 만성 호흡기 질환의 발생률이 증가함에 따라 수술 건수가 증가하고 있습니다. 전 세계에서 수술 건수가 증가함에 따라 기관절개술용 제품에 대한 수요도 빠르게 증가하고 있으며, COVID-19 팬데믹 기간 중 FDA는 공중보건 비상사태에 효과적으로 대응하기 위해 의료진과 환자들이 고품질의 의료기기를 신속하게 이용할 수 있도록 조치를 취했습니다. 조치를 취했습니다.

따라서 긴급 사용 허가(EUA) 규제 전략은 여러 회사가 호흡기 제품 및 액세서리의 가용성을 확장하는 데 도움이 되었습니다. Smiths Medical(미국)은 2020년1월에 Portex 기관 절개 튜브 및 키트를 출시했습니다.에서 기관절개술은 퇴원을 돕고 의료 자원의 활용을 극대화하기 위해 사용되고 있습니다. WHO에 따르면 호흡기 질환은 중저소득 경제권에서 계속 증가하고 있으며, 공해와 담배 사용률이 높을수록 향후 수년간 호흡기 질환의 위험이 높아진다고 합니다. 이에 따라 기관절개용 제품 등 호흡기 보조기구에 대한 수요가 증가하고 있습니다. 천식은 전 세계에서 약 3억 3,400만 명이 앓고 있으며, 소아기의 가장 흔한 만성질환으로 어린이의 약 14%가 앓고 있습니다.

경험이 풍부한 전문가 부족과 복강경 수술에 따른 수술 후 위험은 시장 성장을 제한하고 있습니다. 그러나 일부 시장 진출기업은 예측 기간 중 인체공학적으로 설계된 업그레이드 제품뿐만 아니라 참신하고 진보된 제품을 시장에 출시할 것으로 예상되어 전 세계 시장에 잠재적인 전망을 창출할 것으로 예상됩니다. 북미는 인두암에 대한 혁신적인 기술 및 치료법의 빠른 시장 개척과 첨단 의료 인프라의 존재로 인해 2021년 매출 점유율에서 세계 시장을 주도할 것으로 예상됩니다. 그러나 COPD 및 기타 만성 호흡기 질환의 발병률 증가로 인해 아시아태평양은 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.

기관절개용 제품 시장 보고서 하이라이트

• 기관절개 튜브 유형은 아나필락시스 쇼크, 혼수상태, 식도암, 후두절제술 및 기타 질환의 치료에 사용되며, 2024년 가장 큰 매출 점유율을 차지했습니다.
• 경피적 확장 기관절개술은 중환자실에서 외과적 기관절개술을 거의 완전히 대체하고 장기 입원이 필요한 중증 환자에게 적합하므로 경피적 확장 기관절개술이 2024년 시장 점유율에서 우위를 점했습니다.
• 성인 인구의 만성 호흡기 질환의 높은 유병률로 인해 성인 환자 인구 통계학 부문이 2024년 시장을 주도했습니다.
• 2024년에는 병원 및 수술센터 최종 사용 부문이 시장을 장악했습니다. 고가의 장비를 조달할 수 있는 병원의 큰 용량과 기관 절개 장비를 조작할 수 있는 자격을 갖춘 전문가의 가용성이 이 부문의 성장에 기여하는 주요 요인입니다.
• 한편, 재택치료 최종 용도 부문은 재택 환경에서 장기 치료가 필요한 환자 수가 증가함에 따라 예측 기간 중 가장 빠른 CAGR을 나타낼 것으로 예상됩니다.

목차

제1장 조사 방법과 범위

제2장 개요

제3장 기관절개용 제품 시장 변수, 동향, 범위

• 시장 계통 전망
  • 모시장 전망
  • 관련/부수 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 기관절개용 제품 시장 분석 툴
  • 산업 분석 - Porter의 산업 분석
  • PESTEL 분석

제4장 기관절개용 제품 시장 : 유형별, 추정·동향 분석

• 부문 대시보드
• 기관절개용 제품 시장 : 유형 변동 분석
• 기관절개용 제품 시장 : 유형별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 기관절개 튜브
• 환기 부속품
• 클리닝 & 케어 키트
• 기타

제5장 기관절개용 제품 시장 : 기술별, 추정·동향 분석

• 부문 대시보드
• 기관절개용 제품 시장 : 기술 변동 분석
• 기관절개용 제품 시장 : 기술별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 경피적 기관절개
• 외과적 기관절개

제6장 기관절개용 제품 시장 : 인구통계학별, 추정·동향 분석

• 부문 대시보드
• 기관절개용 제품 시장 : 인구통계학 변동 분석
• 기관절개용 제품 시장 : 인구통계학별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 성인 환자
• 소아·신생아 환자

제7장 기관절개용 제품 시장 : 최종 용도별, 추정·동향 분석

• 부문 대시보드
• 기관절개용 제품 시장 : 최종 용도 변동 분석
• 기관절개용 제품 시장 : 최종 용도별 전망
• 2018-2030년 시장 규모와 예측과 동향 분석
• 병원과 수술 센터
• 외래 수술 센터
• 재택 의료
• 기타

제8장 기관절개용 제품 시장 : 지역별, 추정·동향 분석

• 지역 대시보드
• 지역별 기관절개용 제품 시장 변수 분석
• 기관절개용 제품 시장 : 지역별, 추정·동향 분석 2018-2030년
• 2018-2030년 시장 규모와 예측과 동향 분석
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 스웨덴
  • 노르웨이
• 아시아태평양
  • 일본
  • 중국
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 남아프리카공화국
  • 사우디아라비아
  • 아랍에미리트
  • 쿠웨이트

제9장 경쟁 구도

• 시장 참여 기업의 분류
• 주요 기업 개요
  • Pulmodyne, Inc.
  • Smiths Group plc
  • Medtronic
  • TRACOE Medical GmbH
  • Teleflex, Incorporated.
  • Cook Group
  • Convatec Group PLC
  • Boston Medical Products Inc.
  • Fisher &Paykel Healthcare Limited.
  • ANGIPLAST PRIVATE LIMITED.

KSA

영문 목차

영문목차

Tracheostomy Products Market Growth & Trends:

The global tracheostomy products market size is estimated to reach USD 278.7 million by 2030, expanding at a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The volume of surgical operations has increased with the rising incidence of chronic respiratory illnesses, such as Cardiovascular Diseases (CVDs), diabetes, respiratory diseases, cancer, or other respiratory injuries. As the number of surgeries conducted worldwide continues to rise, the demand for tracheostomy products is growing at a rapid pace. During the COVID-19 pandemic, the FDA had undertaken steps to ensure prompt access to high-quality medical devices for healthcare providers and patients to respond effectively to a public health emergency.

Therefore, the Emergency Use Authorization (EUA) regulatory strategy aids several enterprises in expanding the availability of respiratory products and accessories. Smiths Medical (U.S.) introduced Portex tracheostomy tubes and kits in January 2020. In COVID-19 patients, tracheostomy is being used to aid with weaning and maximizing healthcare resource usage. Respiratory disorders continue to be more prevalent in economies with middle and low income. According to the WHO, the higher the prevalence of pollution and cigarette usage, the greater the risk of respiratory disorders in the years ahead. This has resulted in the increased need for respiratory accessories, such as tracheostomy products. Asthma affects around 334 million people worldwide and it is the most prevalent chronic illness observed during childhood, impacting around 14% of children.

The lack of experienced professionals and the post-operative risks associated with laparoscopy operations are restricting the market growth. However, several market players are expected to introduce novel, advanced, as well as ergonomically designed upgraded products in the market over the forecast period, creating potential prospects for the market across the globe. North America dominated the global market, in terms of revenue share, in 2021 owing to the rapid development of innovative technologies and therapies for throat cancer and the presence of advanced healthcare infrastructure. However, Asia Pacific is expected to witness the fastest CAGR over the forecast period due to the rising incidence of COPD and other chronic respiratory illnesses.

Tracheostomy Products Market Report Highlights:

• The tracheostomy tubes type segment held the largest revenue share in 2024 as these systems are utilized in treatments for anaphylactic shock, coma, esophageal cancer, laryngectomy, and other disorders
• The percutaneous dilatational tracheostomy techniques segment dominated the market in 2024 as this technique has almost completely replaced surgical tracheostomy in the ICU and is more suitable for severely ill patients requiring prolonged hospital stays
• The adult patients demographics segment led the market in 2024 due to the high prevalence of chronic respiratory disorders among the adult population
• The hospitals & surgery centers end-use segment dominated the market in 2024. The larger capacity of hospitals to procure expensive equipment and the availability of qualified specialists to operate tracheostomy devices are the key factors contributing to the segment growth
• The home care settings end-use segment, on the other hand, is expected to register the fastest CAGR over the forecast period due to the rising number of patients requiring long-term care in home settings

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Type
  • 1.2.2. Technique
  • 1.2.3. Demographics
  • 1.2.4. End Use
  • 1.2.5. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
    • 1.4.5.1. Data for primary interviews in North America
    • 1.4.5.2. Data for primary interviews in Europe
    • 1.4.5.3. Data for primary interviews in Asia Pacific
    • 1.4.5.4. Data for primary interviews in Latin America
    • 1.4.5.5. Data for Primary interviews in MEA
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Type outlook
  • 2.2.2. Technique outlook
  • 2.2.3. Demographics outlook
  • 2.2.4. End use outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Tracheostomy Products Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Rising prevalence of respiratory disorders
    • 3.2.1.2. Technological advancement
    • 3.2.1.3. Increasing number of minimally invasive procedures
    • 3.2.1.4. Rising healthcare spending
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost of surgeries and lack of reimbursement
    • 3.2.2.2. Post-surgical complications
• 3.3. Tracheostomy Products Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Tracheostomy Products Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Tracheostomy Products Market: Type Movement Analysis
• 4.3. Tracheostomy Products Market by Type Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Tracheostomy Tubes
  • 4.5.1. Tracheostomy Tubes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Ventilation Accessories
  • 4.6.1. Ventilation Accessories Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Clean & Care Kits
  • 4.7.1. Clean & Care Kits Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Others
  • 4.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Tracheostomy Products Market: Techniques Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Tracheostomy Products Market: Techniques Movement Analysis
• 5.3. Tracheostomy Products Market by Techniques Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Percutaneous Dilatational Tracheostomy
  • 5.5.1. Percutaneous Dilatational Tracheostomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Surgical Tracheostomy
  • 5.6.1. Surgical Tracheostomy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Tracheostomy Products Market: Demographics Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Tracheostomy Products Market: Demographics Movement Analysis
• 6.3. Tracheostomy Products Market by Demographics Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Adult Patients
  • 6.5.1. Adult Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Pediatric/Neonatal Patients
  • 6.6.1. Pediatric/Neonatal Patients Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Tracheostomy Products Market: End Use Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Tracheostomy Products Market: End Use Movement Analysis
• 7.3. Tracheostomy Products Market by End Use Outlook (USD Million)
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. Hospitals & Surgery Centers
  • 7.5.1. Hospitals & Surgery Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Ambulatory Surgical Centers
  • 7.6.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Home Care Settings
  • 7.7.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Others
  • 7.8.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Tracheostomy Products Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Regional Tracheostomy Products Market Movement Analysis
• 8.3. Tracheostomy Products Market: Regional Estimates & Trend Analysis 2018 to 2030 for the following
• 8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 8.5. North America
  • 8.5.1. North America Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. U.S.
    • 7.5.2.1 Key Country Dynamics
    • 7.5.2.2 Competitive Scenario
    • 7.5.2.3 Regulatory Framework
    • 7.5.2.4 Reimbursement scenario
    • 7.5.2.5 U.S. Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Canada
    • 7.5.3.1 Key Country Dynamics
    • 7.5.3.2 Competitive Scenario
    • 7.5.3.3 Regulatory Framework
    • 7.5.3.4 Reimbursement scenario
    • 7.5.3.5 Canada Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.4. Mexico
    • 7.5.4.1 Key Country Dynamics
    • 7.5.4.2 Competitive Scenario
    • 7.5.4.3 Regulatory Framework
    • 7.5.4.4 Reimbursement scenario
    • 7.5.4.5 Mexico Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Europe
  • 8.6.1. Europe Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. UK
    • 8.6.2.1 Key Country Dynamics
    • 8.6.2.2 Competitive Scenario
    • 8.6.2.3 Regulatory Framework
    • 8.6.2.4 Reimbursement scenario
    • 8.6.2.5 UK Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Germany
    • 8.6.3.1 Key Country Dynamics
    • 8.6.3.2 Competitive Scenario
    • 8.6.3.3 Regulatory Framework
    • 8.6.3.4 Reimbursement scenario
    • 8.6.3.5 Germany Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. France
    • 8.6.4.1 Key Country Dynamics
    • 8.6.4.2 Competitive Scenario
    • 8.6.4.3 Regulatory Framework
    • 8.6.4.4 Reimbursement scenario
    • 8.6.4.5 France Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Italy
    • 8.6.5.1 Key Country Dynamics
    • 8.6.5.2 Competitive Scenario
    • 8.6.5.3 Regulatory Framework
    • 8.6.5.4 Reimbursement scenario
    • 8.6.5.5 Italy Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.6. Spain
    • 8.6.6.1 Key Country Dynamics
    • 8.6.6.2 Competitive Scenario
    • 8.6.6.3 Regulatory Framework
    • 8.6.6.4 Reimbursement scenario
    • 8.6.6.5 Spain Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.7. Denmark
    • 8.6.7.1 Key Country Dynamics
    • 8.6.7.2 Competitive Scenario
    • 8.6.7.3 Regulatory Framework
    • 8.6.7.4 Reimbursement scenario
    • 8.6.7.5 Denmark Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.8. Sweden
    • 8.6.8.1 Key Country Dynamics
    • 8.6.8.2 Competitive Scenario
    • 8.6.8.3 Regulatory Framework
    • 8.6.8.4 Reimbursement scenario
    • 8.6.8.5 Sweden Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.9. Norway
    • 8.6.9.1 Key Country Dynamics
    • 8.6.9.2 Competitive Scenario
    • 8.6.9.3 Regulatory Framework
    • 8.6.9.4 Reimbursement scenario
    • 8.6.9.5 Norway Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.7. Asia Pacific
  • 8.7.1. Asia Pacific Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.2. Japan
    • 8.7.2.1 Key Country Dynamics
    • 8.7.2.2 Competitive Scenario
    • 8.7.2.3 Regulatory Framework
    • 8.7.2.4 Reimbursement scenario
    • 8.7.2.5 Japan Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.3. China
    • 8.7.3.1 Key Country Dynamics
    • 8.7.3.2 Competitive Scenario
    • 8.7.3.3 Regulatory Framework
    • 8.7.3.4 Reimbursement scenario
    • 8.7.3.5 China Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.4. India
    • 8.7.4.1 Key Country Dynamics
    • 8.7.4.2 Competitive Scenario
    • 8.7.4.3 Regulatory Framework
    • 8.7.4.4 Reimbursement scenario
    • 8.7.4.5 India Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.5. South Korea
    • 8.7.5.1 Key Country Dynamics
    • 8.7.5.2 Competitive Scenario
    • 8.7.5.3 Regulatory Framework
    • 8.7.5.4 Reimbursement scenario
    • 8.7.5.5 South Korea Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.6. Australia
    • 8.7.6.1 Key Country Dynamics
    • 8.7.6.2 Competitive Scenario
    • 8.7.6.3 Regulatory Framework
    • 8.7.6.4 Reimbursement scenario
    • 8.7.6.5 Australia Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.7.7. Thailand
    • 8.7.7.1 Key Country Dynamics
    • 8.7.7.2 Competitive Scenario
    • 8.7.7.3 Regulatory Framework
    • 8.7.7.4 Reimbursement scenario
    • 8.7.7.5 Thailand Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.8. Latin America
  • 8.8.1. Latin America Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.8.2. Brazil
    • 8.8.2.1 Key Country Dynamics
    • 8.8.2.2 Competitive Scenario
    • 8.8.2.3 Regulatory Framework
    • 8.8.2.4 Reimbursement scenario
    • 8.8.2.5 Brazil Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.26. Argentina
    • 8.8.3.1 Key Country Dynamics
    • 8.8.3.2 Competitive Scenario
    • 8.8.3.3 Regulatory Framework
    • 8.8.3.4 Reimbursement scenario
    • 8.8.3.5 Argentina Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.9. Middle East & Africa
  • 8.9.1. Middle East & Africa Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.2. South Africa
    • 8.9.2.1 Key Country Dynamics
    • 8.9.2.2 Competitive Scenario
    • 8.9.2.3 Regulatory Framework
    • 8.9.2.4 Reimbursement scenario
    • 8.9.2.5 South Africa Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.3. Saudi Arabia
    • 8.9.3.1 Key Country Dynamics
    • 8.9.3.2 Competitive Scenario
    • 8.9.3.3 Regulatory Framework
    • 8.9.3.4 Reimbursement scenario
    • 8.9.3.5 Saudi Arabia Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.4. UAE
    • 8.9.4.1 Key Country Dynamics
    • 8.9.4.2 Competitive Scenario
    • 8.9.4.3 Regulatory Framework
    • 8.9.4.4 Reimbursement scenario
    • 8.9.4.5 UAE Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.9.5. Kuwait
    • 8.9.5.1 Key Country Dynamics
    • 8.9.5.2 Competitive Scenario
    • 8.9.5.3 Regulatory Framework
    • 8.9.5.4 Reimbursement scenario
    • 8.9.5.5 Kuwait Tracheostomy Products Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Key Company Profiles
  • 9.2.1. Pulmodyne, Inc.
    • 9.2.1.1. Company overview
    • 9.2.1.2. Financial performance
    • 9.2.1.3. Product benchmarking
    • 9.2.1.4. Strategic initiatives
  • 9.2.2. Smiths Group plc
    • 9.2.2.1. Company overview
    • 9.2.2.2. Financial performance
    • 9.2.2.3. Product benchmarking
    • 9.2.2.4. Strategic initiatives
  • 9.2.3. Medtronic
    • 9.2.3.1. Company overview
    • 9.2.3.2. Financial performance
    • 9.2.3.3. Product benchmarking
    • 9.2.3.4. Strategic initiatives
  • 9.2.4. TRACOE Medical GmbH
    • 9.2.4.1. Company overview
    • 9.2.4.2. Financial performance
    • 9.2.4.3. Product benchmarking
    • 9.2.4.4. Strategic initiatives
  • 9.2.5. Teleflex, Incorporated.
    • 9.2.5.1. Company overview
    • 9.2.5.2. Financial performance
    • 9.2.5.3. Product benchmarking
    • 9.2.5.4. Strategic initiatives
  • 9.2.6. Cook Group
    • 9.2.6.1. Company overview
    • 9.2.6.2. Financial performance
    • 9.2.6.3. Product benchmarking
    • 9.2.6.4. Strategic initiatives
  • 9.2.7. Convatec Group PLC
    • 9.2.7.1. Company overview
    • 9.2.7.2. Financial performance
    • 9.2.7.3. Product benchmarking
    • 9.2.7.4. Strategic initiatives
  • 9.2.8. Boston Medical Products Inc.
    • 9.2.8.1. Company overview
    • 9.2.8.2. Financial performance
    • 9.2.8.3. Product benchmarking
    • 9.2.8.4. Strategic initiatives
  • 9.2.9. Fisher & Paykel Healthcare Limited.
    • 9.2.9.1. Company overview
    • 9.2.9.2. Financial performance
    • 9.2.9.3. Product benchmarking
    • 9.2.9.4. Strategic initiatives
  • 9.2.10. ANGIPLAST PRIVATE LIMITED.
    • 9.2.10.1. Company overview
    • 9.2.10.2. Financial performance
    • 9.2.10.3. Product benchmarking
    • 9.2.10.4. Strategic initiatives

관련자료